MedTrace Logo

Vitamin K2 Supplementation and Arterial Stiffness in the Renal Transplant Population (The KING Trial)

NCT02517580 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2018-02-09

Study results available
· View outcomes & findings →

Summary

This study is a single arm, single center clinical trial that aims to evaluate the effect of 8 weeks of vitamin K2 replacement (360 mcg/day) on the progression of arterial stiffness in stable renal transplant patients.

Conditions

  • Arterial Stiffness
  • Vitamin K2 Deficiency

Interventions

DIETARY_SUPPLEMENT

Vitamin K2 (MK7)

Sponsors & Collaborators

  • Omicron Pharmaceuticals

    collaborator INDUSTRY

  • Lebanese American University

    lead OTHER

Principal Investigators

  • Sola Aoun Bahous, M.D. Ph.D. · Lebanese American University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • Lebanon

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02517580 on ClinicalTrials.gov